Artegraft Biologic Graft Debuts in Pancreatic Cancer Surgery at Lecheng
James W. Watson2026-09-09T14:24:28+08:00Lecheng introduces Artegraft® biologic vascular graft in China's first pancreatic cancer surgery with celiac artery reconstruction – offering new hope for patients with vascular involvement. Learn more about this breakthrough.











